Loading clinical trials...
Loading clinical trials...
MDRO: Study of Highly Resistant Escherichia Coli
Conditions
Interventions
no Intervention
Locations
13
United States
Harbor-University of California Los Angeles Medical Center
Torrance, California, United States
University of Colorado Denver
Aurora, Colorado, United States
Emory University
Atlanta, Georgia, United States
Ochsner Medical Center
New Orleans, Louisiana, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
Start Date
November 12, 2020
Primary Completion Date
June 1, 2021
Completion Date
June 1, 2021
Last Updated
July 27, 2021
NCT06938867
NCT07318584
NCT07280598
NCT00877708
NCT00363220
NCT00619580
Lead Sponsor
Duke University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions